Recognized asbestos litigation authority and W&L partner Charles M. Ferguson has once again been invited to serve as co-chair for the upcoming Perrin Asbestos Litigation…
Read MoreFirm News: Drugs & Devices
Category: Drugs & Devices
Abbott Recalls Amplatzer Steerable Delivery Sheath Catheter Due to Air Embolisms
Weitz & Luxenberg is currently accepting legal cases from clients who became seriously ill, or had a loved one die, after using an Amplatzer…
Category: Drugs & Devices
W&L Pursuing Cases of Tepezza Causing Hearing Damage
Weitz & Luxenberg is taking cases of severe hearing damage in adults who took Tepezza to treat thyroid eye disease (TED). People across the…
Category: Consumer, Drugs & Devices
$500 Million Cost Savings for Eli Lilly Insulin Settlement
Weitz & Luxenberg is announcing a major victory in our class action lawsuit on behalf of people living with diabetes. Legal counsel for plaintiffs…
Category: Drugs & Devices
A $230 Million Opioid Settlement with Walgreens Reached for San Francisco Represented by W&L and Co-Counsel
On May 17, 2023, San Francisco City Attorney David Chiu announced Walgreens agreed to pay the People of San Francisco $230 million for its…
Category: Consumer, Drugs & Devices
W&L and Co-Counsel Reach $235M Settlement in Altria E-Cig Youth Vaping Crisis
Weitz & Luxenberg and co-lead counsel are pleased to announce a historic $235 million settlement with defendant Altria Group, Inc., in the federal multidistrict…